Developing new medications to treat alcohol use disorder
Medication Development for the Treatment of Alcohol Use Disorder
['FUNDING_U01'] · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · NIH-10917129
This study is looking at new medications that could help people with alcohol use disorder by testing modified versions of existing drugs to see if they can reduce drinking, with the goal of finding better treatments for those who want to manage their alcohol dependence.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER (nih funded) |
| Locations | 1 site (LUBBOCK, UNITED STATES) |
| Trial ID | NIH-10917129 on ClinicalTrials.gov |
What this research studies
This research focuses on creating new medications specifically designed to help individuals struggling with alcohol use disorder (AUD). The team is investigating modified versions of tetracyclines, which have shown promise in reducing alcohol consumption in animal models. By testing these new compounds, the researchers aim to find effective treatments that can help patients manage their alcohol dependence more successfully. The study involves preclinical testing to ensure the safety and efficacy of these new medications before they can be considered for human trials.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with alcohol use disorder who are seeking new treatment options.
Not a fit: Patients who do not have alcohol use disorder or those who are not seeking treatment for their alcohol consumption may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective medications for treating alcohol use disorder, improving outcomes for many patients.
How similar studies have performed: Previous research has shown promise in developing new medications for alcohol use disorder, but this specific approach using chemically modified minocycline is relatively novel.
Where this research is happening
LUBBOCK, UNITED STATES
- TEXAS TECH UNIVERSITY HEALTH SCIS CENTER — LUBBOCK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BERGESON, SUSAN E. — TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
- Study coordinator: BERGESON, SUSAN E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.